Hussman Strategic Advisors’s DexCom DXCM Stock Holding History

Hussman Strategic Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,500	Closed	-$659K	–	261
2026 Q1	$659K	Sell	10,500 -31,500	-75%	-$2.19M	0.14%	226
2025 Q4	$2.79M	Hold	42,000	–	–	0.67%	34
2025 Q3	$2.83M	Buy	+42,000	New	+$3.32M	0.61%	40
2024 Q4	–	Sell	-42,000	Closed	-$2.82M	–	257
2024 Q3	$2.82M	Buy	+42,000	New	+$3.45M	0.69%	41

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Hussman Strategic Advisors's DXCM Position: Q2 2026 in Review

Hussman Strategic Advisors sold out of DexCom (DXCM) in Q2 2026, closing a stake of 10,500 shares — an estimated $659K sold.

Hussman Strategic Advisors first reported a position in DXCM in Q3 2024 and held it in 4 quarters. The position peaked at $2.83M in Q3 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Hussman Strategic Advisors reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
Hussman Strategic Advisors sold 10,500 DexCom shares in Q2 2026, an estimated $659K.
Hussman Strategic Advisors first reported a position in DexCom in Q3 2024 and held it in 4 quarters.
Hussman Strategic Advisors's DexCom position peaked at $2.83M in Q3 2025.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.